Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Conmed ( (CNMD) ) has issued an update.
On August 7, 2025, CONMED Corporation’s Board of Directors declared a quarterly cash dividend of $0.20 per share, which will be payable on October 3, 2025, to shareholders recorded by September 15, 2025. This announcement reflects CONMED’s ongoing commitment to returning value to its shareholders and may positively influence investor sentiment and the company’s market position.
The most recent analyst rating on (CNMD) stock is a Buy with a $97.00 price target. To see the full list of analyst forecasts on Conmed stock, see the CNMD Stock Forecast page.
Spark’s Take on CNMD Stock
According to Spark, TipRanks’ AI Analyst, CNMD is a Outperform.
Conmed’s strong financial performance and positive earnings call are the primary drivers of its stock score. While technical indicators show mixed signals, the company’s fair valuation and strategic focus on growth and operational improvements support a positive outlook.
To see Spark’s full report on CNMD stock, click here.
More about Conmed
Average Trading Volume: 438,387
Technical Sentiment Signal: Sell
Current Market Cap: $1.58B
Find detailed analytics on CNMD stock on TipRanks’ Stock Analysis page.